Bausch Health Companies Inc. expects US approval during the second half of 2020 of its application for the first preservative-free OTC eye drop containing ketotifen for the treatment of itching associated with allergic conjunctivitis.
Bausch submitted to the Food and Drug Administration an abbreviated new drug application for OTC use of preservative-free ketotifen, identified...